Target intelligence / Profile preview

Thiosulfate sulfurtransferase (TST)

Target
TST
Molecular classification
Enzyme, Transferase, Mitochondrial protein, Sulfurtransferase
01

Overview

Thiosulfate sulfurtransferase (TST), commonly known as rhodanese, is a mitochondrial enzyme comprising about 300 amino acids that detoxifies cyanide by transferring a sulfur atom from thiosulfate to cyanide, generating thiocyanate and sulfite. The enzyme is structurally characterized by the rhodanese fold, an α/β sandwich seen in both catalytically active and inactive sulfurtransferase family members. Rhodanese plays diverse biological roles, including cyanide detoxification, iron–sulfur cluster assembly, selenium metabolism, and participation in the biosynthesis of cofactors such as thiamine. The enzyme cycles between a sulfur-free and a persulfide (sulfur-bound) intermediate state during catalysis, with the catalytic cysteine residue (commonly Cys-247) being essential for activity. Thiosulfate is the best characterized exogenous donor for the reaction. The rhodanese domain is present in a broad range of proteins, and variants lacking catalytic activity may act in regulatory or structural roles. Clinically, thiosulfate sulfurtransferase is relevant in cyanide intoxication, where its activity (endogenous and pharmacologically augmented by sodium thiosulfate) provides a critical detoxification pathway[1][5][3][8].

Other names
thiosulfate cyanide transsulfurasethiosulfate thiotransferaserhodaneserhodanase
02

Mechanism of action

Detoxifies cyanide by catalyzing conversion of cyanide to thiocyanate using thiosulfate as a sulfur donor; forms enzyme–sulfur intermediates in a double displacement reaction; produces sulfite and thiocyanate as products[1][3][5]

03

Biological functions

Cyanide detoxificationIron-sulfur cluster formationSelenium metabolismMaintenance of cellular sulfane sulfur poolProsthetic group formation for enzymesThiamine biosynthesisProtein-protein interaction mediator (for inactive domains)Other
04

Disease associations

Cyanide poisoningPotential role in rare metabolic diseasesPossible involvement in mitochondrial dysfunctionOther
05

Safety considerations

Minimal direct safety concerns for inhibition or activation as a therapeutic targetbut overexpression or deficiency may affect cellular sulfane sulfur balance or increase susceptibility to cyanide[1][5]
06

Interacting drugs

Sodium thiosulfate (used to treat cyanide poisoning)

1 more in the full profile.

07

Biomarkers

Increased or decreased activity as a potential biomarker for cyanide exposure or poisoningpossibly mitochondrial function

Beyond the preview

Go deeper on Thiosulfate sulfurtransferase (TST).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thiosulfate sulfurtransferase (TST).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call